Cargando…
QS-21: A Potent Vaccine Adjuvant
Autores principales: | Zhu, Daming, Tuo, Wenbin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4874334/ https://www.ncbi.nlm.nih.gov/pubmed/27213168 http://dx.doi.org/10.4172/2329-6836.1000e113 |
Ejemplares similares
-
An adjuvanted zoster vaccine elicits potent cellular immune responses in mice without QS21
por: Nam, Hyo Jung, et al.
Publicado: (2022) -
Potent response of QS-21 as a vaccine adjuvant in the skin when delivered with the Nanopatch, resulted in adjuvant dose sparing
por: Ng, Hwee-Ing, et al.
Publicado: (2016) -
Development of a minimal saponin vaccine adjuvant based on QS-21
por: Fernández-Tejada, Alberto, et al.
Publicado: (2014) -
Lysosome-Dependent Activation of Human Dendritic Cells by the Vaccine Adjuvant QS-21
por: Welsby, Iain, et al.
Publicado: (2017) -
Meta-Analysis on Randomized Controlled Trials of Vaccines with QS-21 or ISCOMATRIX Adjuvant: Safety and Tolerability
por: Bigaeva, Emilia, et al.
Publicado: (2016)